Financial Instruments and Other Inventory Positions - Additional Information (Details) - Maximum risk of loss $ in Millions |
Dec. 31, 2023
USD ($)
|
|---|---|
| Counterparties not required to post collateral | |
| Fair Value, Concentration of Risk, Financial Statement Captions | |
| Uncollateralized credit exposure | $ 6.7 |
| Notional contract amount | 150.2 |
| One unnamed financial institutional not required to post collateral | |
| Fair Value, Concentration of Risk, Financial Statement Captions | |
| Uncollateralized credit exposure | $ 5.8 |
| X | ||||||||||
- Definition Nominal or face amount used to calculate payments on the derivative asset. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition This item represents disclosure of all significant concentrations of credit risk or market risk arising from the subject financial instrument (as defined), whether from an individual counterparty or groups of counterparties. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. No definition available.
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|